Research ArticleCancer Immunotherapy

Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer

See allHide authors and affiliations

Sci. Signal.  02 Jan 2018:
Vol. 11, Issue 511, eaan0790
DOI: 10.1126/scisignal.aan0790

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article